SEARCH RESULTS FOR: 购买假的单位存款证明【咨询网:ｚｊｗ２１１.ｃｏｍ】宜城得克萨斯A(525 results)

Export results
Filters
Sort By
10
Results Per Page
10
Results/Pg
Company Name Brand Name GMDN Term Name GMDN Term Status FDA Product Code Name FDA Product Code Device Packaged As Sterile Sterilization Prior To Use Issuing Agency Device Size Device Size Type Device Class Implantable

Show Filters

N/A - 00763000810573

LIT 33TH67L DYSTONIA EMANUALS EN
MEDTRONIC, INC.
33TH67L
In Commercial Distribution

  • 00763000810573 ()


  • Deep brain electrical stimulation system

N/A - 00763000810566

LIT 33TH60L DYSTONIA EMANUALS EN
MEDTRONIC, INC.
33TH60L
In Commercial Distribution

  • 00763000810566 ()


  • Deep brain electrical stimulation system

N/A - 00763000810559

LIT 33TH59L DYSTONIA EMANUALS EN
MEDTRONIC, INC.
33TH59L
In Commercial Distribution

  • 00763000810559 ()


  • Deep brain electrical stimulation system

N/A - 00763000810542

LIT 33TH57L DYSTONIA EMANUALS EN
MEDTRONIC, INC.
33TH57L
In Commercial Distribution

  • 00763000810542 ()


  • Deep brain electrical stimulation system

N/A - 00763000810535

LIT 33TH40L DYSTONIA EMANUALS EN
MEDTRONIC, INC.
33TH40L
In Commercial Distribution

  • 00763000810535 ()


  • Deep brain electrical stimulation system

LIXELLE - 14993478010066

The Lixelle(r) beta 2-microglobulin apheresis column is indicated for the treatment of patients with clinically-diagnosed dialysis-related amyloidosis (DRA).
KANEKA CORPORATION
S-25
In Commercial Distribution

  • 04993478010069 ()
  • 14993478010066 ()
  • 24993478010063 ()
N/A

  • Haemoperfusion system absorption column

LIXELLE - 14993478010059

The Lixelle(r) beta 2-microglobulin apheresis column is indicated for the treatment of patients with clinically-diagnosed dialysis-related amyloidosis (DRA).
KANEKA CORPORATION
S-15
In Commercial Distribution

  • 04993478010052 ()
  • 14993478010059 ()
  • 24993478010056 ()
N/A

  • Haemoperfusion system absorption column

LIXELLE - 14993478010042

The Lixelle(r) beta 2-microglobulin apheresis column is indicated for the treatment of patients with clinically-diagnosed dialysis-related amyloidosis (DRA).
KANEKA CORPORATION
S-35
In Commercial Distribution

  • 24993478010049 ()
  • 14993478010042 ()
  • 04993478010045 ()
N/A

  • Haemoperfusion system absorption column

Lixelle - 14993478020232

The Lixelle(r) beta 2-microglobulin apheresis column is indicated for the treatment of patients with clinically-diagnosed dialysis-related amyloidosis (DRA).
KANEKA CORPORATION
S-35
Not in Commercial Distribution

  • 24993478020239 ()
  • 14993478020232 ()
  • 04993478010045 ()
N/A

  • Haemoperfusion system absorption column

Lixelle - 14993478020225

The Lixelle(r) beta 2-microglobulin apheresis column is indicated for the treatment of patients with clinically-diagnosed dialysis-related amyloidosis (DRA).
KANEKA CORPORATION
S-25
Not in Commercial Distribution

  • 24993478020222 ()
  • 14993478020225 ()
  • 04993478010069 ()
N/A

  • Haemoperfusion system absorption column
< 1 2 3 4 5 ... 53 >